Evaluation and treatment of oral candidiasis in HIV/AIDS patients in Enugu, Nigeria

Oral and Maxillofacial Surgery

Volumn 12, Issue 2, 2008, Pages 67-71

  Oji, Chima ^a   Chukwuneke, F ^a  

^a UNIVERSITY OF NIGERIA   (Nigeria)

Author keywords

Enugu; Evaluation; Nigeria; Oral candidiasis in HIV AIDS; Treatment

Indexed keywords

ANTIFUNGAL AGENT; KETOCONAZOLE; MOUTHWASH; NYSTATIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; AIDS RELATED COMPLEX; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MALE; MIDDLE AGED; THRUSH; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CANDIDIASIS, ORAL; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; IMMUNOCOMPROMISED HOST; KETOCONAZOLE; MALE; MIDDLE AGED; MOUTHWASHES; NYSTATIN; TREATMENT OUTCOME;

EID: 58149117661     PISSN: 18651550     EISSN: 18651569     Source Type: Journal    
DOI: 10.1007/s10006-008-0106-8     Document Type: Article

References (28)

1. Aldred MJ, Addy M, Bagg J (1991) Oral health in the terminally ill: A cross sectional pilot survey. Sec Care Dentist 11:59-62
2. Arendorf TM, Walker DM (1980) The prevalence and intra-oral distribution of Candida albicans in man. Arch Oral Biol 25:1-10
3. Bendick C, Scheifele C, Reichert PA (2002) Oral manifestations in 101 Cambodians with HIV/AIDS. J Oral Pathol Med 31:145-150
4. Bianchi PG, Parente F, Cernushi M (1989) The diagnosis of oropharyngeal candidiaisis in patients with the acquired immune deficiency syndrome: is endoscopy always necessary? Am J Gastroenterol 84:143-146
5. Blignaut E, Patton LL, Nittayananta W, Ramirez-Amador V, Ranganathan K, Chattopadhyay A (2006) (A3) HIV phenotypes, oral lesions, and management of HIV-related disease. Adv Dent Res 19:122-129
6. Chidzonga MM (2003) HIV/AIDS orofacial lesions in 156 Zimbabwean patients at referral oral and maxillofacial surgical clinics. Oral Dis 91:317-322
7. Dupont B, Graybill JR, Armstrong D (1992) Fungal infections in AIDS patients. J Med Vet Mycol 30:19-28
8. Fraser VJ, Jones M, Dunkel J (1992) Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 15:414-421
9. Ghannonum MA, Radwan SS (1990) Candida adherence to epithelial cells. CRC, Boca Raton, FL
10. Going RA (2002) Comparison of fluconazole and nystatin oral suspensions for the treatment of oral candidiasis in infants. Pediatr Infect Dis J 21(12):1165-1167
11. Greenspan D, Gange SJ, Philan JA, Navazesh M, Alves ME, MacPhail LA (2004) Incidence of oral lesions in HIV-1-infected women: Reduction with HAART. J Dent Res 83:145-150
12. Hilton JF, MacPhail LA, Pascasio L, Sroussi H, Cheikh B, LaBao ME (2004) Self care intervention to reduce oral candidiasis recurrences in HIV-positive persons: A pilot study. Community Dent Oral Epidemiol 32:190-200
13. Laine L, Dretler RH, Contteas CN, Tauzan C, Koster FM, Sattler F (1992) Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial. Ann Intern Med 117:655-660
14. Lopez DM, Mora SP, Pintado GV, Valencia OE, Uriol PL, Khamashta MA (1992) Clinical, endoscopic, immunologic and therapeutic aspects of oropharyngeal and esopharyngeal candidiasis in HIV infected patients: A survey of 114 cases. Am J Gastroenterol 87:1771-1776
15. Lucas VS (1983) Association of psychotropic drugs, prevalence of denture-related stomatitis and oral candidosis. Community Dent Oral Epidemiol 21:313-316
16. Mathieson R, Dutta SK (1983) Candida esophagitis. Dig Dis Sci 28:365-790
17. Ravera M, Reggiori A, Agliata AM, Rocco RP (1999) Evaluation, diagnosis and treatment of oral and esophageal candidiasis in Ugandan AIDS patients. Emerg Infect Dis 5(2):274-277
18. Nittayananta W, De Rouen T, Arirachakaran P, Laothumthut T, Pangsomboon K, Petsantad S (2006a) Chlorhexidine mouth-rinse in maintenance of oral candidiasis-free period among HIV-infected suspects. Adv Dent Res 19:170
19. Nittayananta W, Nauntofte B, Dabelsteen E, Stolze K, Chanowanna N, Jeales S (2006b) Salivary and oral findings in HIV and HIV-free subjects with a well-controlled consumption of medication. Adv Dent Res 19:168
20. Nyst MJ, Perriens JH, Kimputu L, Lumbila M, Nelson AM, Piot P (1992) Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairean AIDS patients. Ann Soc Belge Med Trop 72:45-52
21. Odds F (1998) Candida and candidiasis, 2nd edn. Bailliere Tindall, London
22. Patricia A, Murray D, Susan LK, Irma M, Jane W, Bruce L (1997) Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients. Clin Ther 3:471-480
23. Pfaller MA, Jones RN, Doern IG, Sader HS, Hollis J, Messer SA (1998) International surveillance of blood stream infection due to Candida. J Clin Microbiol 36:1886-1889
24. Pons V, Greenspan D, Debruin M (1993) Therapy of oropharyngeal candidiasis in HIV infected patients: A randomized, prospective multicenter study group. J Acquir Immune Defic Syndr 6:1311-1316
25. Pons V, Greenspan D, Lozada-Nur F (1997) Oropharyngeal candidiasis in patients with AIDS: Randomized comparison of fluconazole versus nystatin oral suspensions. Clin Infect Dis 24:1204-1207
26. Powderly WG, Gallant JE, Ghannoum MA, Mayer KH, Navarro EE, Perfect JR (1999) Oropharyngeal candidiasis in patients with HIV: Suggested guidelines for therapy. AIDS Res Hum Retrovir 15:1619-1623
27. Raufman JP, Rosenthal LE (1986) Oral candidiasis as a maker for esophageal candidiasis in the acquired immunodefiency syndrome. Ann Intern Med 104:54-58
28. Smith DE, Midgley J, Allan M, Connolly GM, Gazzard B (1991) Itraconazole versus ketoconazole in the treatment of oral and oesophageal candidosis in patients with HIV. AIDS 154:1367-1371